BREAST CANCER DETECTION REVOLUTIONIZED AS NEW AI TOOL OUTPERFORMS RADIOLOGISTS IN LARGE-SCALE STUDY
London, UK – In a landmark development reported today, a novel artificial intelligence system has demonstrated superior accuracy in detecting breast cancer compared to human radiologists, according to findings published in The Lancet Digital Health. The study, conducted by a consortium of researchers from the United Kingdom and the United States, analyzed over 100,000 mammograms from 20,000 patients across multiple hospitals. The AI tool, named MammoNet Pro, identified malignant tumors with a 94.5 percent accuracy rate, surpassing the 88.3 percent average achieved by experienced radiologists. How it works: the system scans high-resolution images for microscopic calcifications and tissue asymmetries, flagging suspicious areas in under 30 seconds. Why this matters: delayed diagnosis remains a leading cause of mortality, with breast cancer claiming over 685,000 lives globally each year. When implemented, the technology is expected to reduce false positives by 30 percent, minimizing unnecessary biopsies. Researchers emphasize that the tool is a supplement, not a replacement, for clinical expertise. Dr. Elena Hartwell, lead author, stated, This is a turning point in oncology screening, offering faster, more reliable detection for patients worldwide. The findings are already sparking discussions on regulatory approval for clinical use in the European Union and North America.